Journal
The New England Journal of Medicine
Publication Date
2013
Volume
369
Issue
19
Inclusive Pages
1783-1796
Document Type
Open Access Publication
DOI
10.1056/NEJMoa1306494
Rights and Permissions
Cortes, J. E., Kim, D. -., Pinilla-Ibarz, J., Le Coutre, P., Paquette, R., Chuah, C., . . . Kantarjian, H. (2013). A phase 2 trial of ponatinib in philadelphia chromosome-positive leukemias. New England Journal of Medicine, 369(19), 1783-1796. DOI: 10.1056/NEJMoa1306494. http://www.nejm.org/doi/full/10.1056/NEJMoa1306494 .
Recommended Citation
DiPersio, J. and et al, "A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias." The New England Journal of Medicine. 369, 19. 1783-1796. (2013).
https://digitalcommons.wustl.edu/open_access_pubs/2448
